BillionToOne, Inc. Class A Common Stock (NASDAQ:BLLN) — Market Cap & Net Worth
Market Cap & Net Worth: BillionToOne, Inc. Class A Common Stock (BLLN)
BillionToOne, Inc. Class A Common Stock (NASDAQ:BLLN) has a market capitalization of $3.21 Billion ($3.21 Billion) as of May 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #4741 globally and #1529 in its home market, demonstrating a -7.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BillionToOne, Inc. Class A Common Stock's stock price $77.49 by its total outstanding shares 41413162 (41.41 Million). Analyse BLLN cash generation efficiency to see how efficiently the company converts income to cash.
BillionToOne, Inc. Class A Common Stock Market Cap History: 2025 to 2026
BillionToOne, Inc. Class A Common Stock's market capitalization history from 2025 to 2026. Data shows growth from $3.39 Billion to $3.21 Billion (0.00% CAGR).
BillionToOne, Inc. Class A Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BillionToOne, Inc. Class A Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
11.11x
BillionToOne, Inc. Class A Common Stock's market cap is 11.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
454.69x
BillionToOne, Inc. Class A Common Stock's market cap is 454.69 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $3.39 Billion | $305.11 Million | $7.45 Million | 11.11x | 454.69x |
Competitor Companies of BLLN by Market Capitalization
Companies near BillionToOne, Inc. Class A Common Stock in the global market cap rankings as of May 2, 2026.
Key companies related to BillionToOne, Inc. Class A Common Stock by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
BillionToOne, Inc. Class A Common Stock Historical Marketcap From 2025 to 2026
Between 2025 and today, BillionToOne, Inc. Class A Common Stock's market cap moved from $3.39 Billion to $ 3.21 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.21 Billion | -5.32% |
| 2025 | $3.39 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of BillionToOne, Inc. Class A Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.21 Billion USD |
| MoneyControl | $3.21 Billion USD |
| MarketWatch | $3.21 Billion USD |
| marketcap.company | $3.21 Billion USD |
| Reuters | $3.21 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BillionToOne, Inc. Class A Common Stock
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, an… Read more